ADMA Biologics, Inc. (ADMA)
17.75
-0.53
(-2.90%)
USD |
NASDAQ |
Jan 15, 15:00
ADMA Biologics SG&A Expense (TTM): 96.37M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 214.26M |
| Aldeyra Therapeutics, Inc. | 9.186M |
| Arcutis Biotherapeutics, Inc. | 253.18M |
| Marker Therapeutics, Inc. | 4.365M |
| CorMedix, Inc. | 75.56M |